Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Intellectual disability, Global developmental delay, and Autistic behavior; and very common findings: Excessive hunger (polyphagia). 50 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 7 | Inability to walk, Seizure, Intellectual disability |
Arms and legs | 4 | Short foot, Tapered finger, Rocker bottom foot |
Digestive system | 4 | Gastroesophageal reflux, Constipation, Feeding difficulties |
Muscles | 3 | Flexion contracture, Joint stiffness present at birth (arthrogryposis multiplex congenita), Neonatal hypotonia |
Pregnancy and birth | 3 | Fetal akinesia sequence, Decreased fetal movement, Neonatal hypotonia |
Growth and development | 2 | Failure to thrive in infancy, Short stature |
Head and neck | 2 | Coarse facial features, Mandibular prognathia |
Bones and joints | 2 | Sideways curvature of the spine (scoliosis), Excessive outward curvature of the upper spine (kyphosis) |
Hormones | 1 | Hypogonadism |
Lungs and breathing | 1 | Sleep apnea |
Skin | 1 | Skin-picking |
Schaaf-Yang Syndrome (SYS) is a rare, paternally derived neurodevelopmental disorder that shares multiple clinical features with the genetically related Prader-Willi syndrome. It usually manifests at birth with muscular hypotonia in all and distal joint contractures in a majority of affected individuals. To date, more than 250 individuals have been identified with a paternally derived pathogenic variant in MAGEL2 [, , , ]. The following description of the phenotypic features associated with this condition is based on these reports. Table 2. Select Features of Schaaf-Yang Syndrome
Feature | % of Personsw/Feature | Comment |
|---|---|---|
DD/ID | 100% | — |
Muscular hypotonia | 100% | — |
Infantile hypotonia | 95%-100% | — |
Feeding difficulties in infancy | 95%-100% | — |
Flexion contractures | 85% | — |
Autistic behavior | 75%-85% | — |
Dysmorphic features | 75%-85% | Incl pointed chin, frontal bossing, low-set ears |
Ocular anomalies | 75%-85% | Incl esotropia, myopia, strabismus |
Behavioral abnormalities | 70%-80% | Incl impulsivity, compulsivity, stubbornness, manipulative behavior, skin picking / automutilation |
Sleep apnea | 70%-80% | — |
Respiratory distress | 65%-75% | — |
Small hands | 65%-75% | Other hand anomalies: tapered fingers, clinodactyly, camptodactyly, brachydactyly, adducted thumbs |
Chronic constipation | 65%-75% | — |
Temperature instability | 60%-70% | — |
Short feet | 55%-65% | — |
fetal movement | 55%-65% | — |
GERD | 50%-60% | — |
Scoliosis | 50%-60% | — |
Short stature | 50%-60% | — |
Polyphagia/Obesity | 30%-40% | Onset in late childhood/adolescence. Frequency of this feature w/age. |
Seizures | 30%-40% | — |
Kyphosis | 25%-35% | — |
Hypogonadism | 15%-65% | 15%-25% of females 55%-65% of males, based on appearance of external genitalia Muscular hypotonia is, to a variable degree, present in almost all neonates with SYS, and can be severe in some instances. Reduced fetal movements may be reported prenatally. |
Source: GeneReviews — "Schaaf-Yang Syndrome"
MAGEL2 encodes MAGE family member L2 (1,249 aa). Probably enhances ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases, possibly through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex.
Schaaf-Yang syndrome is caused by mutations in the MAGEL2 gene on chromosome 15.
MAGEL2 is classified as a druggable target (Enzyme category) with score 0.0.
Penetrance is considered to be 100% for individuals with a pathogenic MAGEL2 variant on their paternal allele, regardless of the sex of the affected individual (i.e., all should display symptoms associated with SYS). Individuals with a pathogenic MAGEL2 variant on their maternal allele will be unaffected.
Source: GeneReviews — "Schaaf-Yang Syndrome"
Formal clinical diagnostic criteria for Schaaf-Yang syndrome (SYS) have not been established.
SYS should be suspected in individuals with the following clinical and suggestive laboratory findings.
Clinical findings
Source: GeneReviews — "Schaaf-Yang Syndrome"
Table 3. Neurodevelopmental Disorders of Interest in the Differential Diagnosis of Schaaf-Yang Syndrome (SYS)
Gene(s)/ Genetic Mechanism | DiffDx Disorder | MOI | Occurrence of Feature in Persons w/DiffDx Disorder |
|---|---|---|---|
ID/DD | ASD | Neonatal hypotonia | Infantile feeding problems |
Prader-Willi syndrome | See footnote 2. | +++ | ++ |
TOR1A | Arthrogryposis multiplex congenita (See SYNE1 Deficiency OMIM PS617468.) | AR | ++ |
Genetic testing for MAGEL2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Schaaf-Yang syndrome has been reported in the published literature.
No approved treatments are currently available for Schaaf-Yang syndrome. The disease remains an area of unmet medical need.
Gene therapy approaches for Schaaf-Yang syndrome have been reported in the published literature.
Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with Schaaf-Yang syndrome, the evaluations summarized (if not performed as part of the evaluation that led to diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with Schaaf-Yang Syndrome
System/Concern | Evaluation | Comment |
|---|---|---|
Constitutional | Measurement of growth parameters | To evaluate for growth deficiency in infancy/childhood obesity in adulthood Gastrointestinal/ |
Feeding | Gastroenterology/ nutrition/ feeding team eval | To incl eval for aspiration risk, nutritional status, signs symptoms of GERD constipation; May require use of special nipple /or nasogastric tube in infancy; Consider eval for gastrostomy tube placement in affected persons w/dysphagia /or aspiration risk. |
Respiratory | Polysomnography | To assess for obstructive /or central sleep apnea1 |
Musculoskeletal | AP lateral radiographs of spine in children adolescents | To evaluate for scoliosis Orthopedics/ physical medicine rehab/ PT OT eval |
Development |
Source: GeneReviews — "Schaaf-Yang Syndrome"
View trials for Schaaf-Yang syndrome
Table 6. Recommended Surveillance for Individuals with Schaaf-Yang Syndrome
System/Concern | Evaluation | Frequency |
|---|---|---|
Development | Monitor developmental progress educational needs. | At each visit Psychiatric/ |
Behavioral | Behavioral assessment for signs of ASD, anxiety, attention, aggressive or self-injurious behavior | Annually Neurologic |
Eyes | Assessment by ophthalmologist | Per ophthalmologist |
Endocrine | Assessment for signs symptoms of puberty appropriate pubertal development from ages 10-17 yrs | At each visit Miscellaneous/ |
Source: GeneReviews — "Schaaf-Yang Syndrome"
Phenotype severity distribution: 3 always present features, 1 very common feature, 9 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Schaaf-Yang syndrome.
22 publications have been identified in PubMed for Schaaf-Yang syndrome. Research spans Basic Science / Preclinical (50%), Case Report / Case Series (32%), and Review / Meta-Analysis (9%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 11 | 50% |
Patient case studies | 7 | 32% |
Research summaries | 2 | 9% |
Testing and diagnosis research | 1 | 5% |
New treatment approaches | 1 | 5% |
Korchak EJ (2026). [PMID: 42094436](https://pubmed.ncbi.nlm.nih.gov/42094436/). *bioRxiv*. [Basic Science / Preclinical]
Buecking J (2026). [PMID: 42146651](https://pubmed.ncbi.nlm.nih.gov/42146651/). *bioRxiv*. [Basic Science / Preclinical]
Laver TW (2026). [PMID: 41916724](https://pubmed.ncbi.nlm.nih.gov/41916724/). *J Med Genet*. [Basic Science / Preclinical]
Pastucha D (2026). [PMID: 41937924](https://pubmed.ncbi.nlm.nih.gov/41937924/). *Appl Clin Genet*. [Case Report / Case Series]
Hashimoto Y (2026). [PMID: 41923794](https://pubmed.ncbi.nlm.nih.gov/41923794/). *Clin Pediatr Endocrinol*. [Case Report / Case Series]
Dos Santos HM (2026). [PMID: 40760912](https://pubmed.ncbi.nlm.nih.gov/40760912/). *Journal of child neurology*. [Basic Science / Preclinical]
Hong YJ (2026). [PMID: 41423862](https://pubmed.ncbi.nlm.nih.gov/41423862/). *Journal of clinical laboratory analysis*. [Basic Science / Preclinical]
Franke F (2025). [PMID: 41168328](https://pubmed.ncbi.nlm.nih.gov/41168328/). *Scientific reports*. [Case Report / Case Series]
Buecking J (2025). [PMID: 40231584](https://pubmed.ncbi.nlm.nih.gov/40231584/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Heimdörfer D (2025). [PMID: 40945516](https://pubmed.ncbi.nlm.nih.gov/40945516/). *American journal of human genetics*. [Diagnostic / Biomarker]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 6:53 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Schaaf-Yang syndrome
SMN1
Spinal muscular atrophy type 1 |
AR |
+++ |
Interstitial deletions on chromosome 16q223 | Chromosome 16q22 deletion syndrome (OMIM 614541) | AD(isolated cases) | ++ |
VAMP1 | Congenital myasthenic syndromes4 | ADAR | + |
Source: GeneReviews — "Schaaf-Yang Syndrome"
Developmental assessment
To incl motor, adaptive, cognitive, speech-language eval; Eval for early intervention/ special education Psychiatric/ |
Behavioral | Neuropsychiatric eval | For persons age 12 mos: screening for behavior concerns incl sleep disturbances, ADHD, anxiety, /or features suggestive of ASD |
Neurologic | Neurologic eval | Consider EEG if seizures are a concern. |
Eyes | Ophthalmologic eval | To assess for vision, abnormal ocular movement, strabismus |
Genitourinary | Assessment for genital hypoplasia /or pubertal development (in adolescents adults) on physical exam | Consider referral to:; Urologist in males w/undescended testes;; Endocrinologist in those w/evidence of hypoplastic genitalia /or hypogonadism. |
Endocrine system lipid metabolism | Baseline laboratory testing3 | — |
Genetic counseling | By genetics professionals4 | To obtain a pedigree inform affected persons families re nature, MOI, implications of Schaaf-Yang syndrome to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with Schaaf-Yang Syndrome Manifestation/Concern | Treatment | Considerations/Other Poor weight gain/ Failure to thrive |
GERD | Standard therapy | — |
Constipation | Stool softeners, prokinetics, osmotic agents, or laxatives as needed | — |
Short stature | Consideration of GH therapy | Affected persons w/short stature should benefit from off-label GH supplementation to improve body height. |
AI-curated news mentioning Schaaf-Yang syndrome
Updated Feb 9, 2026
On Rare Disease Day, families affected by Schaaf-Yang Syndrome are celebrated, highlighting their resilience and the importance of community advocacy. The Foundation for Prader-Willi Research encourages awareness and sharing of personal stories to inspire hope and recognition for those with rare diseases.